68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions
Clear Cell Renal Cell Carcinoma
Interventions
DRUG

68Ga-NY104 PET/CT

"68Ga-NY104 PET/CT will be performed at baseline, 6 months, 12 months, and 24 months after radiation therapy if the tumor is under control. If CT or MRI shows any suspicious recurrence or metastasis, 68Ga-NY104 PET/CT can be performed at the decision of the urology oncologist or radiation oncologist.~The scan begins 1 hour after intravenous injection of 68Ga-NY104."

DRUG

18F-FDG PET/CT

18F-FDG PET/CT will be performed at baseline and 6 months after radiation therapy. The scan begins 1 hour after intravenous injection of 18F-FDG.

RADIATION

Radiation Therapy

Radiation therapy will be delivered to cover as much metastasis as possible if not all. For new lesions after radiation plus systemic therapy, if the new lesions are considered suitable for RT, RT can be delivered again without changing systemic therapy.

DRUG

Systemic therapy

Systemic therapy will be delivered to patients to control the tumor. Possible regimen includes targeted therapy alone, immunotherapy alone, and targeted therapy combined with immunotherapy. The treatment regimen will be decided according to the urology oncologist.

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors
collaborator

Peking University First Hospital

OTHER

lead

Peking Union Medical College Hospital

OTHER